Trials / Sponsors / Joseph Jurcic
Joseph Jurcic
Academic / Other · 2 registered clinical trials.
| Status | Trial | Phase | Started |
|---|---|---|---|
| Terminated | Combination of Fedratinib and Decitabine for Myeloproliferative Neoplasms (MPN)- Accelerated Phase (AP)/Blast Myeloproliferative Neoplasm | Phase 1 | 2022-01-28 |
| Withdrawn | Actinium-225-Lintuzumab in Patients With Acute Myeloid Leukemia Acute Myeloid Leukemia | Phase 1 | 2019-02-28 |